FDA Approvals in Oncology: July-September 2025
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
For August 2025, the editors of AACR's journals highlighted studies on liquid biopsy for brain cancer, new treatment strategies...
New clinical trials are exploring an array of CAR T-cell approaches for children with cancers of the brain and...
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
Researchers at the AACR Annual Meeting 2024 examined new treatment options for brain tumors.
You’re working away on your latest project when your stomach suddenly growls. Stepping away from your desk, you head...
In the United States, nearly 24,000 people are estimated to receive a brain or nervous system cancer diagnosis in 2020....
Compared to treatment advances for other types of cancer, progress in treating brain cancer has been frustratingly slow. Still,...
May is Brain Cancer Awareness Month, and this week, the sharpest minds in brain cancer research will convene in...